Naloxone	naloxone	CHEMICALS	O	OTHERS	I
reverses	reverses	O	O	O	O
the	the	O	O	O	O
antihypertensive	antihypertensive	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
clonidine	clonidine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
unanesthetized	unanesthetized	O	O	O	O
,	,	O	O	O	O
spontaneously	spontaneously	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
rats	rats	O	O	O	O
the	the	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
and	and	O	O	O	O
heart	heart	O	O	O	O
rate	rate	O	O	O	O
produced	produced	O	O	O	O
by	by	O	O	O	O
intravenous	intravenous	O	O	O	O
clonidine	clonidine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
5	5	O	O	O	O
to	to	O	O	O	O
20	20	O	O	O	O
micrograms/kg	micrograms/kg	O	O	O	O
,	,	O	O	O	O
was	was	O	O	O	O
inhibited	inhibited	O	O	O	O
or	or	O	O	O	O
reversed	reversed	O	O	O	O
by	by	O	O	O	O
nalozone	nalozone	O	O	OTHERS	I
,	,	O	O	O	O
0.2	0.2	O	O	O	O
to	to	O	O	O	O
2	2	O	O	O	O
mg/kg	mg/kg	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
effect	effect	O	O	O	O
of	of	O	O	O	O
100	100	O	O	O	O
mg/kg	mg/kg	O	O	O	O
alpha-methyldopa	alpha-methyldopa	O	O	O	O
was	was	O	O	O	O
also	also	O	O	O	O
partially	partially	O	O	O	O
reversed	reversed	O	O	O	O
by	by	O	O	O	O
naloxone	naloxone	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Naloxone	naloxone	CHEMICALS	O	OTHERS	I
alone	alone	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
affect	affect	O	O	O	O
either	either	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
or	or	O	O	O	O
heart	heart	O	O	O	O
rate	rate	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
brain	brain	O	O	O	O
membranes	membranes	O	O	O	O
from	from	O	O	O	O
spontaneously	spontaneously	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
rats	rats	O	O	O	O
clonidine	clonidine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
10(-8	10(-8	O	O	O	O
)	)	O	O	O	O
to	to	O	O	O	O
10(-5	10(-5	O	O	O	O
)	)	O	O	O	O
M	m	O	O	O	O
,	,	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
influence	influence	O	O	O	O
stereoselective	stereoselective	O	O	O	O
binding	binding	O	O	O	O
of	of	O	O	O	O
[3H]-naloxone	[3h]-naloxone	O	O	O	O
(	(	O	O	O	O
8	8	O	O	O	O
nM	nm	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
naloxone	naloxone	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
10(-8	10(-8	O	O	O	O
)	)	O	O	O	O
to	to	O	O	O	O
10(-4	10(-4	O	O	O	O
)	)	O	O	O	O
M	m	O	O	O	O
,	,	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
influence	influence	O	O	O	O
clonidine-suppressible	clonidine-suppressible	O	O	O	O
binding	binding	O	O	O	O
of	of	O	O	O	O
[3H]-dihydroergocryptine	[3h]-dihydroergocryptine	O	O	O	O
(	(	O	O	O	O
1	1	O	O	O	O
nM	nm	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
findings	findings	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
in	in	O	O	O	O
spontaneously	spontaneously	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
rats	rats	O	O	O	O
the	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
central	central	O	O	O	O
alpha-adrenoceptor	alpha-adrenoceptor	O	O	O	O
stimulation	stimulation	O	O	O	O
involve	involve	O	O	O	O
activation	activation	O	O	O	O
of	of	O	O	O	O
opiate	opiate	O	O	O	O
receptors	receptors	O	O	O	O
.	.	O	O	O	O

As	as	O	O	O	O
naloxone	naloxone	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
clonidine	clonidine	CHEMICALS	O	OTHERS	I
do	do	O	O	O	O
not	not	O	O	O	O
appear	appear	O	O	O	O
to	to	O	O	O	O
interact	interact	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
receptor	receptor	O	O	O	O
site	site	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
observed	observed	O	O	O	O
functional	functional	O	O	O	O
antagonism	antagonism	O	O	O	O
suggests	suggests	O	O	O	O
the	the	O	O	O	O
release	release	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
endogenous	endogenous	O	O	O	O
opiate	opiate	O	O	O	O
by	by	O	O	O	O
clonidine	clonidine	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
alpha-methyldopa	alpha-methyldopa	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
possible	possible	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
opiate	opiate	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
central	central	O	O	O	O
control	control	O	O	O	O
of	of	O	O	O	O
sympathetic	sympathetic	O	O	O	O
tone	tone	O	O	O	O
.	.	O	O	O	O

